NNCN
Ellen Tauscher, Former Under Secretary of State for Arms Control and International Security and Member of Congress, Named to NCCN Foundation Board
The NCCN Foundation welcomes Ellen Tauscher, Special Envoy for Strategic Stability and Missile Defense, former Under Secretary of State for Arms Control and International Security and Member of Congress, to the NCCN Foundation Board of Directors, chaired by ABC News veteran, Sam Donaldson.
FORT WASHINGTON, PA - The NCCN Foundation, which through private philanthropy and grants advances the mission of the National Comprehensive Cancer Network® (NCCN®) to improve the quality and effectiveness...
Highlights of the NCCN 17th Annual Conference Include Presentations on Lung Cancer Screening, Melanoma, and Non-Hodgkin`s Lymphomas
NCCN presented the new NCCN Guidelines for Lung Cancer Screening and updates to the NCCN Guidelines for Melanoma and Non-Hodgkin`s Lymphomas at the NCCN 17th Annual Conference.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) held the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. The latest updates in clinical practice decision-making in cancer care were presented, inc...
NCCN Roundtable Considers Challenges in Optimal Care for Patients: Who Decides?
An expert panel focused on the current landscape of decision-making for patients with cancer, the influence of payors on those decisions, and how these factors impact oncologists and patients during the National Comprehensive Cancer Network® (NCCN®) 17th Annual Conference.
HOLLYWOOD, FL - In recent years, the factors which have contributed to decision-making for the treatment of cancer have become increasingly complex. Tumor-specific biology, the role of government and payors, and the...
NCCN Presents New Guidelines for Acute Lymphoblastic Leukemia
The new NCCN Guidelines for Acute Lymphoblastic Leukemia were presented at the NCCN 17th Annual Conference on March 17, 2012.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) has issued its first ever NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Acute Lymphoblastic Leukemia (ALL). The new guidelines were presented by the co-chairs of the NCCN ALL Panel, Joseph C. Alvarnas, MD, Director of Medical Quality and Associate Director in the D...
NCCN Opens 17th Annual Conference with Roundtable Discussion on Cancer Care and Corporate America
ABC News veteran and anchor, Sam Donaldson, led a panel discussion that addressed the critical issues related to the delivery of cancer care. The panel included cancer survivors and representatives from business, industry, medicine, and public policy.
HOLLYWOOD, FL - The National Comprehensive Cancer Network® (NCCN®) opened its 17th Annual Conference with a roundtable discussion entitled, Cancer and Corporate America: Business as Usual? ABC News veteran and anchor, Sam Donaldson, mode...
NCCN to Hold 17th Annual Conference: Sam Donaldson and Clifford Goodman Lead Roundtable Discussions on Critical Issues in Cancer Care
The NCCN 17th Annual Conference will take place March 14 - 18 at The Westin Diplomat in Hollywood, Florida. This year`s conference features two roundtable discussions, Cancer and Corporate America: Business as Usual? and Optimal Care for Patients: Who Decides? New NCCN Guidelines for Acute Lymphoblastic Leukemia, Adolescent and Young Adult (AYA) Oncology, and Lung Cancer Screening will also be presented.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) will hold th...
NCCN Announces New Guidelines for Adolescent and Young Adult (AYA) Oncology
The first version of the NCCN Guidelines for Adolescent and Young Adult (AYA) Oncology are now available on-line at NCCN.org.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) announces that it has issued new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Adolescent and Young Adult (AYA) Oncology. AYA patients are defined in the guidelines as individuals 15 to 39 years of age at initial cancer diagnosis. The guidelines address the critica...
NCCN Collaborates with AVEO and Astellas on Innovative Cancer Research
NCCN recently received a research grant from AVEO Pharmaceuticals and Astellas Pharma, Inc. to evaluate the role of tivozanib in the treatment of solid tumors. Tivozanib is a potent, selective, long half-life inhibitor of all three VEGF receptors that is designed to optimize VEGF blockade while minimizing off-target toxicities.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced that it has entered into a collaborati...
New Release of NCCN Guidelines for Patients: Colon Cancer; Updated NCCN Guidelines for Patients: Prostate Cancer
New NCCN Guidelines for Patients™: Colon Cancer and Updated NCCN Guidelines for Patients™: Prostate Cancer are now available on-line at NCCN.com. The same authoritative source referenced by physicians and other health care professionals is now written for and available to patients and their caregivers.
FORT WASHINGTON, PA -In order to provide people with cancer and their caregivers state-of-the-art treatment information in patient-friendly language, the National Comprehensive Can...


